Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac oxidative stress and QoL in healthy women
NCT04751721Unknown
- Sponsor
- İzmir Bakırçay University
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by İzmir Bakırçay University. Primary endpoints: Oxidative Stress Parameters, Serum Trace Elements and 1 more. Status: unknown.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04751721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04751721.